*Cost at time of publication
The burgeoning obesity market is also driving investment at Novo Nordisk, which is spending $6 billion on expanding its Kalundborg, Denmark facility, which makes APIs including semaglutide, the active ingredient in its diabetes and weight loss drugs Ozempic and Wegovy
If TSH is low and free T4 is elevated, you are definitively overmedicated
And rapid weight loss may alter iron metabolism in ways researchers are still studying
Basic measurements: This involves key info such as your current weight and BMI, waist size, blood pressure, and any symptoms that may suggest insulin resistance
Take away message Semaglutide can be an effective tool for managing Type 2 diabetes and aiding weight loss, but it comes with potential risks, including the loss of lean mass and high costs